DERIVES D'IMIDAZOLE PENTACYCLIQUES CONDENSES UTILISES EN TANT QUE MODULATEURS DE L'ACTIVITE DU TNF

• 收藏
• 分享

专利权人:

SANOFI;UCB BIOPHARMA SPRL

发明人:

HEER, JAG PAUL,KEYAERTS, JEAN

申请号：

CA3018907

公开号：

CA3018907A1

申请日:

2017.03.31

申请国别(地区):

CA

年份:

2017

代理人:

摘要：

A series of fused pentacyclic imidazole derivatives, being potent modulators of f benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders； neurological and neurodegenerative disorders； pain and nociceptive disorders； cardiovascular disorders； metabolic disorders； ocular disorders； and oncological disorders. In particular, the present invention is concerned with 5,7,8,15-tetrahydro-6H-8,15- methanobenzimidazo[1,2-b][2,5]benzodiazocin-6-one derivatives and analogs thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/